ACP5 and renal carcinoma: Other studies identified significant associations between elevated plasma levels of tartrate-resistant acid phosphatase 5b (TRAcP-5b) (67, 68), osteoprotegerin (OPG) (69, 70), and osteopontin, and presence of BM in PCa and renal cancer patients (71, 72).